Biolox
Device Joint Replacement Hips, Knees
PDI 04546540608291
General payments
$4,709,814
Research payments
$771,801
Through program year 2025, $4,709,814 in general payments and $771,801 in research payments were reported against Biolox (Joint Replacement Hips, Knees).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $9,275 | 32 |
| 2025 | Research | $43,242 | 6 |
| 2024 | General | $24,052 | 26 |
| 2024 | Research | $350,131 | 67 |
| 2023 | General | $1,005,961 | 28 |
| 2023 | Research | $168,095 | 36 |
| 2022 | General | $1,478,469 | 58 |
| 2022 | Research | $176,476 | 19 |
| 2021 | General | $2,192,057 | 73 |
| 2021 | Research | $33,858 | 10 |
Breakdown
The top 5 of 23 recipients; each share is of general payments naming this product in 2025.
The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 8 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
217 general · 138 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.